← All indications
Rhinitis
Inflammation of the NASAL MUCOSA, the mucous membrane lining the NASAL CAVITIES.
Subtype terms (4)
More specific conditions that are subtypes of Rhinitis in the MeSH hierarchy.
- Rhinitis, Allergic
190 drugs (76 approved, 114 experimental)
- Rhinitis, Atrophic
1 drug approved
- Rhinitis, Vasomotor
14 drugs (13 approved, 1 experimental)
- Rhinosinusitis
Drugs by status
Approved for this indication (7)
Phase 4 trials (14)
Phase 3 trials (19)
Phase 2 trials (10)
Organizations
Organization Involved with Phase 4 Indications (87)
- Meda
- Takeda
- McNeil
- Schering-Plough
- AstraZeneca
- Merck
- Pfizer
- Sanofi
- Alcon
- Allergopharma GmbH & Co. KG
- Bayer
- California Allergy and Asthma Medical Group, Inc.
- GlaxoSmithKline
- HAL Allergy
- Handok Pharmaceuticals Co., Ltd.
- Institut für Atemwegsforschung GmbH
- Menarini Group
- ORA, Inc.
- PharmEvo Pvt Ltd
- Sunovion
- Western Sky Medical Research
- Strategic Biosciences
- National Institutes of Health (NIH)
- National Heart, Lung, and Blood Institute (NHLBI)
- Bernstein, Jonathan A., M.D.
- Hoosier Cancer Research Network
- Indira Gandhi Medical College
- Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy
- Iuliu Hatieganu University of Medicine and Pharmacy
- Katholieke Universiteit Leuven
- +57 more
Organization Involved with Phase 3 Indications (107)
- Abbott
- Actavis
- Ache Laboratorios Farmaceuticos S.A.
- Actelion
- Sandoz
- Allergy Therapeutics
- Stallergenes
- Merck KGaA
- Aventis
- Perrigo
- Apotex
- Novartis
- Allergan
- Biomedical Development Corporation
- Circassia Limited
- Clinical Research International Limited
- Eurofarma Laboratorios S.A.
- Faes Farma, S.A.
- Hanlim Pharm. Co., Ltd.
- Greer Laboratories
- Inmunotek S.L.
- Leti Pharma GmbH
- Magna Pharmaceuticals, Inc.
- SamA Pharmaceutical Co., Ltd
- Sponsor GmbH
- Teva
- Ahn-Gook Pharmaceuticals Co.,Ltd
- Boehringer Ingelheim
- Chong Kun Dang Pharmaceutical
- Committee on Chinese Medicine and Pharmacy
- +77 more
Organization Involved with Phase 2 Indications (92)
- 3E Therapeutics Corporation
- RespiVert
- Regeneron
- Ligand Pharmaceuticals
- ISTA Pharmaceuticals
- Astellas
- Bausch & Lomb
- Shionogi
- AOBiome LLC
- Anergis
- Antigen Laboratories, Inc.
- Biolipox AB
- CMP Therapeutics Ltd
- Danisco
- Dart NeuroScience, LLC
- Evolutec Group
- Harrison Clinical Research
- Immunomic Therapeutics, Inc.
- Max Zeller Soehne AG
- Nuvo Research Inc.
- Orexo AB
- Oxagen Ltd
- Parexel
- Palau Pharma S.A.
- Rigel Pharmaceuticals
- Yakult Honsha Co., LTD
- Dynavax Technologies Corporation
- Thai Traditional Medical Knowledge Fund
- National Institute of Allergy and Infectious Diseases (NIAID)
- University of Pennsylvania
- +62 more
Organization Involved with Phase 1 Indications (33)
- Daiichi Sankyo
- Roche
- Gilead Sciences
- Genentech
- MedImmune
- Mylan
- INC Research
- PharmaKing
- Korea Research Foundation
- Gachon University
- Korea University
- Northwestern University
- Stanford University
- Dalhousie University
- University of Copenhagen
- Xencor
- Procter and Gamble
- Sumitomo Dainippon
- East West Medical Research Institute
- Beijing Institute of Otolaryngology
- University of Texas, Galveston
- University of North Carolina at Chapel Hill
- ICON
- Government of Canada
- Metronomia Clinical Research GMBH
- Thermo Fisher Scientific
- Synteract, Inc.
- ClinResearch, GmbH
- Prolytic GmbH
- pharm-analyt GmbH
- +3 more
Organization Involved with Other Experimental Indications (34)
- Cosmetique Active International
- Enovate Biolife Pvt Ltd
- United Allergy Services
- Verifomics LLC
- German Research Foundation
- The Netherlands Asthma Foundation
- National Institute of Environmental Health Sciences (NIEHS)
- Aarhus University
- Maastricht University
- Tzu Chi University
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Federal University of Uberlandia
- Guangzhou Medical University
- Hong Kong Baptist University
- Hospital Civil Juan I. Menchaca
- University of Guadalajara
- University of Sussex
- Utrecht University
- University of Bergen
- Laval University
- Tsinghua University
- University of Vienna
- Government of Mexico
- Innovaderm
- Scripps
- University of Mississippi
- Finnish Institute of Occupational Health
- Lundbeck
- Kyowa Hakko Kogyo
- Shiraz University
- +4 more